News
-
Edge computing promises to revolutionise AI energy efficiency. As AI adoption surges, infrastructure faces immense power demands. A new joint paper by Arm and SCSP highlights edge computing as a solution, advocating for AI processing closer to its point of use to bolster energy security and competitiveness.
-
ASG King & Fowler secures Airbus approval for TSA line. The Liverpool-based aerospace specialist’s £2 million investment in a fully automated tartaric sulphuric anodising line positions it as a strategic supplier for REACH-compliant aerospace components, enhancing its capabilities to process large aluminium parts sustainably.
-
Microchip Technology has unveiled a sub-nanosecond optical timing system. The TimeProvider 4500 v3 grandmaster clock delivers precise terrestrial synchronisation over 800 km, offering a GNSS-independent solution for critical infrastructure and telecommunications operators seeking higher resilience against satellite signal disruption and interference.
-
SGS and Yili forge a pioneering global partnership. The agreement aims to enhance quality across the dairy production chain, focusing on safety, sustainability, and innovation. By integrating digital systems and zero-carbon initiatives, the collaboration seeks to elevate the Chinese dairy industry’s global standing.
-
Brands face intense competition amid evolving consumer behaviours. An IGD report outlines strategies for brand growth with insights and examples. Private labels are closing in on brand dominance, while brands must leverage visibility, innovation, and emotional connections to maintain market share.
-
Newquay AFC enhances sustainability with solar panels and battery storage. The installation at Mount Wise Stadium aims to utilise renewable energy and contribute to the National Grid, supported by Cornwall Council’s Community Levelling Up Programme and the UK Shared Prosperity Fund.
-
FDA approves new menopause drug that reduces hot flashes. Elinzanetant, a non-hormonal treatment, has shown significant efficacy in reducing hot flashes and enhancing sleep quality, offering a crucial alternative for women unable to use existing hormone therapies. This approval marks a significant advancement in menopausal healthcare options.
-
Semaglutide shows cardiovascular benefits beyond mere fat reduction. The SELECT trial demonstrates that semaglutide’s protective effects on cardiovascular health are not solely due to weight loss. This could imply broader therapeutic applications for semaglutide, potentially reshaping treatment protocols for patients with obesity and cardiovascular disease.
-
Endress+Hauser opens a cutting-edge facility in Nesselwang. The €17 million investment enhances development and production capabilities, focusing on sustainability and innovation. The carbon-neutral site, powered by geothermal and solar energy, adds 3,500 square meters for precision temperature instruments vital to the food and beverage industry.
-
Managing thermal applications is increasingly critical for industries. The Eurotherm by Watlow EPM platform offers a data-centric, distributed automation solution tailored for diverse applications, promising efficiency and operational growth. This platform ensures seamless integration of components within thermal processes for consistent performance.
© 2b Publishing 2026.